AAAAAA

   
Results: 1-9 |
Results: 9
Deletion at 3p25.3-p23 is frequently encountered in endocrine pancreatic tumours and is associated with metastatic progression
Authors: Barghom, A Komminoth, P Bachmann, D Rutimann, K Saremaslani, P Muletta-Feurer, S Perren, A Roth, J Heitz, PU Speel, EJM
Citation: A. Barghom et al., Deletion at 3p25.3-p23 is frequently encountered in endocrine pancreatic tumours and is associated with metastatic progression, J PATHOLOGY, 194(4), 2001, pp. 451-458
Somatic mutation and germline variants of MINPP1, a phosphatase gene located in proximity to PTEN on 10q23.3, in follicular thyroid carcinomas
Authors: Gimm, O Chi, HB Dahia, PLM Perren, A Hinze, R Komminoth, P Dralle, H Reynolds, PR Eng, C
Citation: O. Gimm et al., Somatic mutation and germline variants of MINPP1, a phosphatase gene located in proximity to PTEN on 10q23.3, in follicular thyroid carcinomas, J CLIN END, 86(4), 2001, pp. 1801-1805
Putative tumor suppressor loci at 6q22 and 6q23-q24 are involved in the malignant progression of sporadic endocrine pancreatic tumors
Authors: Barghorn, A Speel, EJM Farspour, B Saremaslani, P Schmid, S Perren, A Roth, J Heitz, PU Komminoth, P
Citation: A. Barghorn et al., Putative tumor suppressor loci at 6q22 and 6q23-q24 are involved in the malignant progression of sporadic endocrine pancreatic tumors, AM J PATH, 158(6), 2001, pp. 1903-1911
Clonality analysis
Authors: Perren, A Komminoth, P
Citation: A. Perren et P. Komminoth, Clonality analysis, MORPHOLOGY METHODS, 2001, pp. 403-412
Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal isletcells
Authors: Perren, A Komminoth, P Saremaslani, P Matter, C Feurer, S Lees, JA Heitz, PU Eng, C
Citation: A. Perren et al., Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal isletcells, AM J PATH, 157(4), 2000, pp. 1097-1103
Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors
Authors: Gimm, O Perren, A Weng, LP Marsh, DJ Yeh, JJ Ziebold, U Gil, E Hinze, R Delbridge, L Lees, JA Mutter, GL Robinson, BG Komminoth, P Dralle, H Eng, C
Citation: O. Gimm et al., Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors, AM J PATH, 156(5), 2000, pp. 1693-1700
Hospital admissions due to adverse drug reactions
Authors: Lepori, V Perren, A Marone, C
Citation: V. Lepori et al., Hospital admissions due to adverse drug reactions, SCHW MED WO, 129(24), 1999, pp. 915-922
Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast
Authors: Perren, A Weng, LP Boag, AH Ziebold, U Thakore, K Dahia, PLM Komminoth, P Lees, JA Mulligan, LM Mutter, GL Eng, C
Citation: A. Perren et al., Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast, AM J PATH, 155(4), 1999, pp. 1253-1260
Clonal analysis of sporadic pancreatic endocrine tumours
Authors: Perren, A Roth, J Muletta-Feurer, S Saremaslani, P Speel, EJM Heitz, PU Komminoth, P
Citation: A. Perren et al., Clonal analysis of sporadic pancreatic endocrine tumours, J PATHOLOGY, 186(4), 1998, pp. 363-371
Risultati: 1-9 |